Traws Pharma TRAW
NASDAQ TRAW
$0.55 -0.05 (-8.17%)
As of: Oct 1, 2026 · 3:59 PM EDT

Traws Pharma (TRAW) Liabilities and Shareholders Equity (2012 - 2026)

Updated

Traws Pharma (TRAW) posted Liabilities and Shareholders Equity of $11.47 million for Q2 2026, down 26.6% from $15.62 million a year earlier but up 40.6% from the prior quarter.

Analysis

Traws Pharma (TRAW) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends

At the end of FY2025, Traws Pharma's Liabilities and Shareholders Equity came in at $10.62 million, down 57.5% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -11.9% (FY2020 to FY2025).
  • In prior years, Traws Pharma's Liabilities and Shareholders Equity was $24.96 million in FY2024 (+10.0%), $22.68 million in FY2023 (-42.4%), $39.37 million in FY2022 (-29.0%) and $55.48 million in FY2021 (+177.6%).
  • Quarterly Liabilities and Shareholders Equity has run from a low of $8.16 million in Q1 2026 to a high of $59.99 million in Q3 2021 over five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity has declined in each of the last three quarters, with an average decline of 21.3% over the last eight quarters.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q4 2021, with growth of 177.6%; the weakest was Q3 2024, with a decline of 67.0%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $8.16 million (Q1 2026), $10.62 million (Q4 2025) and $12.44 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Traws Pharma 6.00 Mn -12.39 Mn - 11.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.47 Mn
Mar 31, 2026 8.16 Mn
Dec 31, 2025 10.62 Mn
Sep 30, 2025 12.44 Mn
Jun 30, 2025 15.62 Mn
Mar 31, 2025 19.06 Mn
Dec 31, 2024 24.96 Mn
Sep 30, 2024 8.94 Mn
Jun 30, 2024 18.69 Mn
Mar 31, 2024 18.17 Mn
Dec 31, 2023 22.68 Mn
Sep 30, 2023 27.04 Mn
Jun 30, 2023 30.47 Mn
Mar 31, 2023 35.06 Mn
Dec 31, 2022 39.37 Mn
Sep 30, 2022 43.78 Mn
Jun 30, 2022 48.07 Mn
Mar 31, 2022 51.42 Mn
Dec 31, 2021 55.48 Mn
Sep 30, 2021 59.99 Mn
API Access

Traws Pharma Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TRAW&period=max&api_key=YOUR_API_KEY